Bjørn Moum

15.4k total citations · 4 hit papers
179 papers, 9.7k citations indexed

About

Bjørn Moum is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Bjørn Moum has authored 179 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Genetics, 114 papers in Epidemiology and 57 papers in Surgery. Recurrent topics in Bjørn Moum's work include Inflammatory Bowel Disease (123 papers), Microscopic Colitis (106 papers) and Eosinophilic Esophagitis (26 papers). Bjørn Moum is often cited by papers focused on Inflammatory Bowel Disease (123 papers), Microscopic Colitis (106 papers) and Eosinophilic Esophagitis (26 papers). Bjørn Moum collaborates with scholars based in Norway, Denmark and Sweden. Bjørn Moum's co-authors include Morten H. Vatn, Jørgen Jahnsen, Tomm Bernklev, I. Lygren, Magne Henriksen, Jostein Sauar, Inger Camilla Solberg, Marte Lie Høivik, Kathrine Frey Frøslie and Ole Høie and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

Bjørn Moum

172 papers receiving 9.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort

2007 872 citations Jørgen Jahnsen, Bjørn Moum et al. profile →
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

2008 536 citations Inger Camilla Solberg, Jørgen Jahnsen et al. Scandinavian Journal of Gastroenterology profile →
Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study

2007 526 citations Inger Camilla Solberg, Morten H. Vatn et al. profile →
Geographical variability and environmental risk factors in inflammatory bowel disease

2013 461 citations Morten H. Vatn, Bjørn Moum et al. Gut profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Bjørn Moum	6.8k	5.9k	3.4k	1.2k	1.1k	179	9.7k
Jean–Frédéric Colombel	7.0k 1.0×	5.5k 0.9×	2.7k 0.8×	1.6k 1.4×	951 0.8×	75	8.9k
A. Hillary Steinhart	6.5k 1.0×	5.1k 0.9×	2.3k 0.7×	1.5k 1.3×	724 0.6×	146	8.5k
Sandro Ardizzone	6.9k 1.0×	5.2k 0.9×	3.6k 1.1×	1.5k 1.3×	670 0.6×	236	10.7k
Jørgen Jahnsen	5.0k 0.7×	4.7k 0.8×	2.3k 0.7×	1.4k 1.2×	1.3k 1.1×	149	7.6k
Millie D. Long	4.6k 0.7×	3.8k 0.6×	2.3k 0.7×	918 0.8×	1.4k 1.2×	271	8.1k
Russell D. Cohen	6.7k 1.0×	5.2k 0.9×	2.7k 0.8×	1.6k 1.4×	641 0.6×	210	9.0k
Gary R. Lichtenstein	5.7k 0.8×	4.6k 0.8×	2.3k 0.7×	1.4k 1.2×	591 0.5×	237	8.6k
Pia Munkholm	5.3k 0.8×	4.0k 0.7×	2.5k 0.7×	842 0.7×	952 0.8×	110	7.2k
Alain Bitton	4.6k 0.7×	3.4k 0.6×	2.3k 0.7×	1.4k 1.2×	592 0.5×	203	7.1k
Bas Oldenburg	4.2k 0.6×	3.3k 0.6×	2.5k 0.7×	939 0.8×	585 0.5×	208	7.7k

Countries citing papers authored by Bjørn Moum

Since Specialization

Citations

This map shows the geographic impact of Bjørn Moum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørn Moum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørn Moum more than expected).

Fields of papers citing papers by Bjørn Moum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørn Moum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørn Moum. The network helps show where Bjørn Moum may publish in the future.

Co-authorship network of co-authors of Bjørn Moum

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørn Moum. A scholar is included among the top collaborators of Bjørn Moum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørn Moum. Bjørn Moum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Høivik, Marte Lie, David J. Warren, Nils Bolstad, et al.. (2023). Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring. Scandinavian Journal of Gastroenterology. 58(8). 863–873. 18 indexed citations

Louis, Édouard, Antonino Spinelli, Simon Travis, et al.. (2023). The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease. Crohn s & Colitis 360. 5(2). otad006–otad006. 6 indexed citations

Småstuen, Milada Cvancarova, et al.. (2023). Risk of Cancer in Patients With Crohn’s Disease 30 Years After Diagnosis (the IBSEN Study). Crohn s & Colitis 360. 5(4). otad057–otad057. 2 indexed citations

Zhao, Mirabella, Mikael Lördal, Ebbe Langholz, et al.. (2022). Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway. Alimentary Pharmacology & Therapeutics. 56(6). 989–1006. 9 indexed citations

Jelsness‐Jørgensen, Lars‐Petter, Bjørn Moum, Tore Grimstad, et al.. (2022). The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients. Scandinavian Journal of Gastroenterology. 57(6). 683–689. 5 indexed citations

Medhus, Asle W., et al.. (2021). First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study. Scandinavian Journal of Gastroenterology. 56(10). 1163–1168. 8 indexed citations

Brackmann, Stephan, Milada Cvancarova, Marte Lie Høivik, et al.. (2020). Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study. BMJ Open Gastroenterology. 7(1). e000361–e000361. 11 indexed citations

Detlie, Trond Espen, et al.. (2019). Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside. Alimentary Pharmacology & Therapeutics. 50(4). 397–406. 46 indexed citations

Palm, Øyvind, Milada Cvancarova, Tomm Bernklev, et al.. (2019). The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study). Inflammatory Bowel Diseases. 26(1). 114–124. 15 indexed citations

10.

Frigstad, Svein Oskar, Marte Lie Høivik, Jørgen Jahnsen, et al.. (2019). Pain Severity and Vitamin D Deficiency in IBD Patients. Nutrients. 12(1). 26–26. 13 indexed citations

11.

Høivik, Marte Lie, Milada Cvancarova, David J. Warren, et al.. (2018). Switching from originator to biosimilar infliximab – real world data of a prospective 18 months follow-up of a single-centre IBD population. Scandinavian Journal of Gastroenterology. 53(6). 692–699. 39 indexed citations

12.

Palm, Øyvind, Milada Cvancarova, Inger Camilla Solberg, et al.. (2018). Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study. Scandinavian Journal of Gastroenterology. 53(10-11). 1250–1256. 30 indexed citations

13.

Høivik, Marte Lie, et al.. (2018). Regional differences in anti-TNF-α therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study. Scandinavian Journal of Gastroenterology. 53(8). 952–957. 8 indexed citations

14.

Huppertz‐Hauss, Gert, Eline Aas, Marte Lie Høivik, et al.. (2016). Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis. Gastroenterology Research and Practice. 2016. 1–9. 8 indexed citations

15.

Opheim, Randi, Marte Lie Høivik, Tomm Bernklev, Lars‐Petter Jelsness‐Jørgensen, & Bjørn Moum. (2016). The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life. Gastroenterology Research and Practice. 2016. 1–9. 10 indexed citations

16.

Frigstad, Svein Oskar, Marte Lie Høivik, Jørgen Jahnsen, et al.. (2016). Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scandinavian Journal of Gastroenterology. 52(1). 100–106. 81 indexed citations

17.

Jelsness‐Jørgensen, Lars‐Petter, Tomm Bernklev, Øistein Hovde, et al.. (2015). Patients’ perceptions of quality of care and follow-up in inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 51(4). 434–441. 16 indexed citations

18.

Hovde, Øistein, et al.. (2014). Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies.. Europe PMC (PubMed Central). 43 indexed citations

19.

Høivik, Marte Lie, Bjørn Moum, Inger Camilla Solberg, et al.. (2012). Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut. 62(3). 368–375. 202 indexed citations

20.

Moum, Bjørn & Anders Ekbom. (2005). Ulcerative colitis, colorectal cancer and colonoscopic surveillance. Scandinavian Journal of Gastroenterology. 40(8). 881–885. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact